Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2003-12-24
2009-08-18
Mondesi, Robert (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C435S007100
Reexamination Certificate
active
07576183
ABSTRACT:
The invention provides therapeutic compositions useful in the treatment of bacterial superantigen mediated conditions, such as Toxic Shock Syndrome. The compositions comprise genetically engineered bifunctional polypeptides containing a specific T-cell receptor binding domain and a specific MHC class II receptor binding domain, each targeting non-overlapping epitopes on a superantigen molecule against which they are designed. The anti-superantigen “receptor mimetics” or “chimeras” are rationally designed to recreate the modality of superantigen binding directly to both the TCR and the MHC-II receptor, and are capable of acting as decoys for superantigen binding, effectively out-competing the host T-cell and MHC-II receptors, the natural host receptors.
REFERENCES:
patent: 4751180 (1988-06-01), Cousens et al.
patent: 4935233 (1990-06-01), Bell et al.
patent: 5990275 (1999-11-01), Whitlow et al.
patent: 2004/0224408 (2004-11-01), Girard et al.
patent: WO01/70245 (2001-09-01), None
Anderson et al. The Journal of Biological Chemistry, vol. 276, No. 36, pp. 33452-33457, 2001.
Hong-Geller et al. Journal of Biological Chemistry, vol. 279, No. 7, pp. 5676-5684 , paper published Feb. 13, 2004 ,Electronically available Nov. 16, 2003.
Anderson et al. , Journal of Biological Chemistry, vol. 276, No. 36, pp. 33452-33457, 2001.
Riley et al. ,Protein Engineering, vol. 9, No. 2 pp. 223-230, 1996.
Kieke et al. Journal of MOlecular Biology vol. 307, pp. 1305-1315, 2001.
Lehnert et al., 2001, “Structure-Based Design of a Bispecific Receptor Mimic That Inhibits T Cell Responses to a Superantigen”, Biochemistry 40: 4222-8.
Jardetzky, et al., 1994, “Three-Dimensional Structure of a Human Class II Histocompatibility Molecule Complexed with Superantigen”, Nature 368: 711-8.
Kim et al., 1994, “Toxic Shock Syndrome Toxin-1 Complexed with a Class II Major Histocompatibility Molecule HLA-DR1”, Science 266: 1870-4.
Fields et al., 1996, “Crystal Structure of a T-Cell Receptor β-Chain Complexed with a Superantigen”, Nature 384: 188-92.
Li et al., 1998, “Three-Dimensional Structure of the Complex Between a T Cell Receptor β Chain and the Superantigen Staphylococcal Enterotoxin B”, Immunity 9: 807-816.
Reiser et al., 1996, “Costimulatory B7 Molecules in the Pathogenesis of Infectious and Autoimmune Diseases”, N Engl J Med 335: 1369-77.
Haddad, J., 2002, “Cytokines and Related Receptor-Mediated Signaling Pathways”, Biochem. Biophys. Res. Comm. 297: 700-13.
Choi et al., 1989, “Interaction ofStaphylococcus aureusToxin “Superantigens” with Human T Cells”, Proc Natl Acad Sci U S A 86: 8941-5.
Sundberg et al., 2002, “So Many Ways of Getting In the Way: Diversity in the Molecular Architecture of Superantigen-Dependent T-Cell Signaling Complexes”, Curr. Opin. Immunol. 14: 36-44.
Papageorgiou et al., 1998, “Crystal Structure of Microbial Superantigen Staphylococcal Enterotoxin B at 1.5 Resolution: Implications for Superantigen Recognition by MHC Class II Molecules and T-Cell Receptors”, J. Mol. Biol. 277: 61-79.
Prasad et al., 1997, “Refined Structures of Three Crystal Forms of Toxic Shock Syndrome Toxin-1 and of a Tetramutant with Reduced Activity”, Protein Sci. 6: 1220-7.
Chi et al., 2002, “Zinc-Mediated Dimerization and Its Effect on Activity and Conformation of Staphylococcal Enterotoxin Type C”, J. Biol. Chem. 277: 22839-46.
Kappler et al., 1989, “Vβ-Specific Stimulation of Human T Cells by Staphylococcal Toxins”, Science 244: 811-813.
Fraser, 1989, “High-Affinity Binding of Staphylococcal Enterotoxins A and B to HLA-DR”, Nature 339: 221-223.
Kreiswirth et al., 1993, “Evidence for a Clonal Origin of Methicillin Resistance inStaphylococcus aureus”, Science 259: 227-230.
Pearson, 2002, ‘Superbug’ Hurdles Key Drug Barrier, Nature 418: 469.
Matthys et al., 1995, “Anti-Gamma Interferon and Anti-Interleukin-6 Antibodies Affect Staphylococcal Enterotoxin B-Induced Weight Loss, Hypoglycemia, and Cytokine Release in D-Galactosamine-Sensitized and Unsensitized Mice”, Infect. Immun.63:1158-1164.
Papageorgiou et al., 1996, “Crystal Stucture of a Biologically Inactive Mutant of Toxic Shock Syndrome Toxin-1 at 2.5 A Resolution”, Protein Sci. 5: 1737-41.
Roussel et al., 1997, “Crystal Structure of the Streptococcal Superantigen SPE-C: Dimerization and Zinc Binding Suggest a Novel Mode of Interaction with MHC Class II Molecules”, Nat. Struct. Biol. 4: 635-643.
Li et al., 1997, “The Superantigen Streptococcal Pyrogenic Exotoxin C (SPE-C) Exhibits a Novel Mode of Action”, J. Exp. Med. 186: 375-383.
Proft et al., 1999, “Identification and Characterization of Novel Superantigens fromStreptococcuspyogenes”, J. Exp. Med. 189: 89-102.
Fraser et al., 2000, “Superantigens—Powerful Modifiers of the Immune System”, Molecular Medicine Today 6: 125-132.
Rosec & Gigaud, 2002, “Staphylococcal Enterotoxin Genes of Classical and New Types Detected by PCR in France”, Intl. Jl. Food Microbiol, 77:61-70.
Hakansson et al., 2000, “The Crystal Structure of Staphylococcal Enterotoxin H: Implications for Binding Properties to MHC Class II and TcR Molecules”, JMB, 302:527-537.
Cottrez et al., 1994, “Analysis of the Vβ Specificity of Superantigen Activation with a Rapid and Sensitive Method using RT PCR and an Automatic DNA Analyser”, J. Immunol. Methods, 172:85-94.
Kieke et al., 2001, “High Affinity T Cell Receptors from Yeast Display Libraries Block T Cell Activation by Superantigens”, J. Mol. Biol. 307: 1305-1315.
Fontenot et al., 1995, “Human Immunodeficiency Virus (HIV) Antigens: Structure and Serology of Multivalent Human Mucin MUC1-HIV V3 Chimeric Proteins”, Proc. Natl. Acad. Sci USA 92:315-319.
Maratea et al,. 1985, “Deletion and Fusioin Analysis of the Phage φX174 Lysis GeneE”, Gene 40:39-46.
Murphy et al., 1986, “Genetic Contruction, Expression, and Melanoma-Selective Cytotoxicity of a Diphtheria Toxin-Related αMelanocyte-Stimulating Hormone Fusion Protein”, Proc. Natl. Acad. Sci. USA 83:8258-8262.
Ridgway et al., 1996, “Knobs-Into-Holes' Engineering of Antibody CH3 Domains for Heavy Chain Heterodimerization”, Protein Eng. 9: 617-621.
Adamian & Liang, “Interhelical Hydrogen Bonds and Spatial Motifs in Membrane Proteins: Polar Clamps and Serine Zippers”, Proteins 47:209-218, 2002.
Atwell et al., 1997, “Stable Heterodimers from Remodeling the Domain Interface of a Homodimer Using a Phage Display Library”, J. Mol. Biol. 270: 26-35.
Galanos et al., 1979, “Galactosamine-induced Sensitization to the Lethal Efects of Endotoxin”, Proc. Natl. Acad. Sci. USA 76: 5939-5943.
Miethke et al. 1992, “T Cell-Mediated Lethal Shock Triggered in Mice by the Superantigen Staphylococcal Enterotoxin B: Critical Role of Tumor Necrosis Factor”, J. Exp. Med. 175: 91-98.
Lowell et al., 1996, “Intranasal and Intramuscular Proteosome-Stphylococcal Enterotoxin B (SEG) Toxoid Vaccines: Immunogenicity and Efficacy against Lethal SEB Intoxication in Mice”, Infect. Immun. 64:1706-1713.
Balaban et al., 2000, “Prevention of Diseases Caused byStaphylococcus aureususing the Peptide RIP”, Peptides 21:1301-1311.
Bernal et al., 1999, “Superantigens in Human Disease”, Jl. Clin. Immunol., 19:149-157.
Leung et al., 1995, “The Role of Superantigens in Skin Disease”, Jl. Invest. Dermatology, 105:37S-42S.
Sanchez and Sali, 1999, “Comparative Protein Structure Modeling in Genomics”, J. Comp. Phys. 151: 388-401.
Arcus et al, 2002, “The Three-Dimensional Structure of a Superantigen-Like Protein, SET3, from a Pathogenicity Island of theStaphylococcus aure
Gupta Goutam
Hong-Geller Elizabeth
Lehnert Nancy M.
Shiflett Patrick R.
Los Alamos National Security LLC
Mondesi Robert
Shahnan-Shah Khatol S.
Sharples Kenneth N.
LandOfFree
Structure-based receptor MIMICS targeted against bacterial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Structure-based receptor MIMICS targeted against bacterial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Structure-based receptor MIMICS targeted against bacterial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4102466